These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 23712295)

  • 21. Irritable bowel syndrome: is the colonic mucosa to blame?
    Hoffman JM
    Neurogastroenterol Motil; 2012 Dec; 24(12):1051-3. PubMed ID: 23176660
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genetic risk factors for post-infectious irritable bowel syndrome following a waterborne outbreak of gastroenteritis.
    Villani AC; Lemire M; Thabane M; Belisle A; Geneau G; Garg AX; Clark WF; Moayyedi P; Collins SM; Franchimont D; Marshall JK
    Gastroenterology; 2010 Apr; 138(4):1502-13. PubMed ID: 20044998
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The putative role of the intestinal microbiota in the irritable bowel syndrome.
    Collins SM; Denou E; Verdu EF; Bercik P
    Dig Liver Dis; 2009 Dec; 41(12):850-3. PubMed ID: 19740713
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mucosal immune cell numbers and visceral sensitivity in patients with irritable bowel syndrome: is there any relationship?
    Braak B; Klooker TK; Wouters MM; Welting O; van der Loos CM; Stanisor OI; van Diest S; van den Wijngaard RM; Boeckxstaens GE
    Am J Gastroenterol; 2012 May; 107(5):715-26. PubMed ID: 22488080
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diarrhoea-predominant irritable bowel syndrome: an organic disorder with structural abnormalities in the jejunal epithelial barrier.
    Martínez C; Lobo B; Pigrau M; Ramos L; González-Castro AM; Alonso C; Guilarte M; Guilá M; de Torres I; Azpiroz F; Santos J; Vicario M
    Gut; 2013 Aug; 62(8):1160-8. PubMed ID: 22637702
    [TBL] [Abstract][Full Text] [Related]  

  • 26. T-cell activation in patients with irritable bowel syndrome.
    Ohman L; Isaksson S; Lindmark AC; Posserud I; Stotzer PO; Strid H; Sjövall H; Simrén M
    Am J Gastroenterol; 2009 May; 104(5):1205-12. PubMed ID: 19367268
    [TBL] [Abstract][Full Text] [Related]  

  • 27. On the fiftieth anniversary. Postinfectious irritable bowel syndrome: mechanisms related to pathogens.
    Grover M; Camilleri M; Smith K; Linden DR; Farrugia G
    Neurogastroenterol Motil; 2014 Feb; 26(2):156-67. PubMed ID: 24438587
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Overlap between irritable bowel syndrome and inflammatory bowel disease.
    Spiller RC
    Dig Dis; 2009; 27 Suppl 1():48-54. PubMed ID: 20203497
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Abdominal pain in Irritable Bowel Syndrome: a review of putative psychological, neural and neuro-immune mechanisms.
    Elsenbruch S
    Brain Behav Immun; 2011 Mar; 25(3):386-94. PubMed ID: 21094682
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The functional-organic dichotomy: postinfectious irritable bowel syndrome and inflammatory bowel disease-irritable bowel syndrome.
    Grover M; Herfarth H; Drossman DA
    Clin Gastroenterol Hepatol; 2009 Jan; 7(1):48-53. PubMed ID: 18848909
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Irritable bowel syndrome and inflammatory bowel disease: Is there a connection?].
    Mearin F; Perelló A; Balboa A
    Gastroenterol Hepatol; 2009 May; 32(5):364-72. PubMed ID: 19442413
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Protease activated receptor 4 status of mast cells in post infectious irritable bowel syndrome.
    Han W; Wang Z; Lu X; Guo C
    Neurogastroenterol Motil; 2012 Feb; 24(2):113-9, e82. PubMed ID: 22151913
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Post-infectious irritable bowel syndrome].
    Serghini M; Karoui S; Boubaker J; Filali A
    Tunis Med; 2012 Mar; 90(3):205-13. PubMed ID: 22481191
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neuro-immune interactions in inflammatory bowel disease and irritable bowel syndrome: future therapeutic targets.
    Kraneveld AD; Rijnierse A; Nijkamp FP; Garssen J
    Eur J Pharmacol; 2008 May; 585(2-3):361-74. PubMed ID: 18417115
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Will corticosteroids and other anti-inflammatory agents be effective for diarrhea-predominant irritable bowel syndrome?
    Crentsil V
    Med Hypotheses; 2005; 65(1):97-102. PubMed ID: 15893125
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Interleukin-10: A Compelling Therapeutic Target in Patients With Irritable Bowel Syndrome.
    Kumar S; Shukla R; Ranjan P; Kumar A
    Clin Ther; 2017 Mar; 39(3):632-643. PubMed ID: 28237672
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Focus on irritable bowel syndrome.
    Scalera A; Loguercio C
    Eur Rev Med Pharmacol Sci; 2012 Sep; 16(9):1155-71. PubMed ID: 23047498
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Post-infectious irritable bowel syndrome].
    Pallotti F; Fogacci E; Frisoni C; Serra M; Bellacosa L; Carini G; Cremon C; De Giorgio R; Stanghellini V; Corinaldesi R; Barbara G
    Clin Ter; 2011; 162(2):157-61. PubMed ID: 21533323
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mucosal cytokine imbalance in irritable bowel syndrome.
    Macsharry J; O'Mahony L; Fanning A; Bairead E; Sherlock G; Tiesman J; Fulmer A; Kiely B; Dinan TG; Shanahan F; Quigley EM
    Scand J Gastroenterol; 2008; 43(12):1467-76. PubMed ID: 18752146
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Changes of cytokine levels in a mouse model of post-infectious irritable bowel syndrome.
    Yang B; Zhou X; Lan C
    BMC Gastroenterol; 2015 Apr; 15():43. PubMed ID: 25886744
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.